Phathom Pharmaceuticals, Inc.

US$5.25As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:PHATHealthcare
Country USA
PE (Fwd) •••
TSR 7Y CAGR (19.28%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 0.65
PE TTM —
TSR TTM (61.25%)
Mkt cap US$417.0M
ROIC (8.64%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$6.33
20.63%
0.41%
Hold 8|12|8|7|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.06
0.06
0.06
0.06
1.24%
2.31%
2.20%
(1.07%)
Revenue$M
42.64
44.91
46.29
45.76
2.13%
8.79%
9.76%
4.61%
Peers (US$417.0M)
Cap (US$)
PE
414.7M
2.554x
419.8M
—
Capital
TTM
5Y
10Y
Leveragex
3.337
(0.034)
(0.030)
EBIT/Intx
0.564
1.283
1.392
Own earn%
(240.52)
9.33
24.29
Sh yield%
23.85
13.46
13.24
Owners
Insiders/Inst%
3.40
54.72
Short interest%
2.22
SBC / revenue%
0.41
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
19–26
$1 testx
0.2
Incr. ROIC%
58